经尿道等离子腔内剜除术与切除术治疗前列腺增生

目的:对比分析经尿道双极等离子前列腺剜除术(PKEP)和前列腺切除术(PKRP)治疗高危良性前列腺增生患者的疗效和安全性。方法:回顾性分析2007年6月至2009年9月共收治高危良性前列腺增生症患者112例,随机分为PKEP组和PKRP组治疗,比较2组患者手术时间、术中出血量、切除组织量、术后尿失禁数和术后住院时间。结果:除住院时间外,2组患者手术时间、术中出血量、切除组织量、术后尿失禁数差异明显,均具有统计学意义(P<0.05),而2组患者术后RUVI、PSS、QOL、Qmax比较差异无统计学意义(P>0.05)。结论:2种术式治疗高危良性前列腺增生症患者均疗效满意,但PKEP在手术时间、术中出血量、切除组织量、术后并发症方面更具优势,值得推广。

PKEK and PKRP treatment for high-risk benign prostatic hyperplasia via urethra

Objective: To compare the efficacy and safety of high risk benign prostatic hyperplasia treated with bipolar plasmakinetic resection and bipolar plasmakinetic enucleation via urethra.Methods: 112 cases of high risk benign prostatic hyperplasia were analyzed retrospectively from June,2007 to Sept.2009,which were randomly divided into PKRP group and PKEP group.The operative time,the blood lose,the resected tissue weight,the rate of incontinence of urine and the post-operation hospital stay were compared between two groups.Results: Besides post-operation hospital stay,the operative time,the blood lose,the resected tissue weight and the rate of incontinence of urine were significant different between two groups,which existed statistically significance(P<0.05),but there was no significant difference in post-operative RUV,IPSS,QOL,Qmax between two groups(P>0.05).Conclusion: The two surgical procedures have the same significant efficacy in the treatment of high risk benign prostatic hyperplasia,but the operative time,blood lose,the resected tissue weight,the rate of incontinence of urine of PKEP are superior to those of PKRP,and it is worth promoting.